Roche Holding AG ADR

OTC: RHHBY

GO
/marketstate/country/us

After Hours

/zigman2/quotes/208994986/delayed

$

44.90

Change

+0.04 +0.09%

Volume

Volume 538

Sep 23, 2020, 4:41 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/208994986/delayed

Previous close

$ 46.31

$ 44.86

Change

-1.45 -3.13%

Day low

Day high

$44.70

$45.68

Open
Open: 45.64

52 week low

52 week high

$35.04

$47.15

Open

Market cap

$315.95B

Average volume

972,130

P/E ratio

23.37

Rev. per Employee

$615,038

EPS

1.92

Dividend

1.14

Div yield

1.60%

Ex dividend date

3/19/20

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/rhhby

MarketWatch News on RHHBY

  1. It’s Likely Too Late for Regeneron’s Virus Treatment

    10:00 a.m. Sept. 11, 2020

    - Bill Alpert

  2. Stocks March Ahead, Unfazed by Weak Jobs Report

    11:36 a.m. Sept. 2, 2020

    - Teresa Rivas

  3. Roche Announces a Covid-19 Antigen Test

    9:53 a.m. Sept. 2, 2020

    - Josh Nathan-Kazis

  4. BioMarin Stock’s Near-Term Growth Is Gone, Analyst Says

    9:43 a.m. Aug. 20, 2020

    - Bill Alpert

  5. U.S. Will Demand Restoration of Iran Sanctions

    6:24 p.m. Aug. 19, 2020

    - Ben Walsh

  6. BioMarin Slumps After FDA Rejects Its Hemophilia Gene Therapy

    12:19 p.m. Aug. 19, 2020

    - Bill Alpert

  7. BioMarin Slumps After FDA Rejects Its Hemophilia Gene Therapy

    12:19 p.m. Aug. 19, 2020

    - Bill Alpert

  8. Regeneron Signs Up Roche to Help Manufacture Covid-19 Antibody

    11:42 a.m. Aug. 19, 2020

    - Josh Nathan-Kazis

  9. Buy Merck for Its Unappreciated Pipeline, Says Goldman

    10:47 a.m. Aug. 3, 2020

    - Bill Alpert

  10. 6 Health-Care Stocks to Buy for the Second Half of 2020

    11:34 a.m. July 15, 2020

    - Lauren R. Rublin

  11. Loading more headlines...
/news/nonmarketwatch/company/us/rhhby

Other News on RHHBY

  1. Airlines look to antigen tests as pandemic fix

    2:25 p.m. Sept. 23, 2020

    - Seeking Alpha

  2. PerkinElmer Covid-19 Test Heads FDA List for Superior Detection

    11:56 a.m. Sept. 22, 2020

    - GuruFocus.com

  3. AstraZeneca's Lynparza Gets CHMP Nod for Two New Indications

    11:21 a.m. Sept. 22, 2020

    - Zacks.com

  4. COVID-19 test makers struggling to meet demand

    10:19 a.m. Sept. 22, 2020

    - Seeking Alpha

  5. Company News for Sep 21, 2020

    9:34 a.m. Sept. 21, 2020

    - Zacks.com

  6. Top Analyst Reports for JPMorgan, PayPal & Novo Nordisk

    3:14 p.m. Sept. 18, 2020

    - Zacks.com

  7. Roche Stock Rallies on Promising Coronavirus Drug Results

    1:47 p.m. Sept. 18, 2020

    - InvestorPlace.com

  8. Loading more headlines...
/news/pressrelease/company/us/rhhby

Press Releases on RHHBY

  1. Blood Cancer Drugs Market Growth, Revenue, Demand and Forecast to 2025

    4:03 p.m. Sept. 23, 2020

    - Market Insight Reports

  2. At 8.3% CAGR, Home Healthcare Market Size to Hit USD 447.6 billion by 2026

    1:35 p.m. Sept. 23, 2020

    - Market Insight Reports

  3. Ulcerative Colitis Market Huge Growth Opportunities and Trends to 2026

    9:01 a.m. Sept. 23, 2020

    - Market Insight Reports

  4. Loading more headlines...

Rates »

Link to MarketWatch's Slice.